Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine. - Plewnia,C.; Hoppe,J.; Hiemke,C.; Bartels,M.; Cohen,LG.; Gerloff,C. (Neurosci Lett, 2002)